Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1988 | 12-1987 | 12-1986 | 12-1985 | 12-1984 | |
| Sales | 4,936,991 | 4,387,876 | 3,807,634 | 3,360,273 | 3,103,962 |
| Cost of Goods | 2,353,159 | 2,101,875 | 1,868,402 | 1,694,934 | 1,565,338 |
| Gross Profit | 2,583,832 | 2,286,001 | 1,939,232 | 1,665,339 | 1,538,624 |
| Operating Expenses | 1,481,974 | 1,281,205 | 1,061,023 | 929,126 | 862,444 |
| Operating Income | 1,102,017 | 1,005,671 | 878,611 | 737,147 | 676,518 |
| Interest Expense | 85,000 | 125,205 | 86,352 | 98,095 | 94,223 |
| Other Income | 38,459 | 56,659 | 26,439 | 55,478 | 63,899 |
| Pre-tax Income | 1,055,476 | 937,125 | 818,698 | 694,530 | 646,194 |
| Income Tax | 303,449 | 304,566 | 278,238 | 229,195 | 243,619 |
| Net Income Continuous | 752,027 | 632,559 | 540,460 | 465,335 | 402,575 |
| Net Income | $752,027 | $632,559 | $540,460 | $465,335 | $402,575 |
| EPS Basic Total Ops | 0.42 | 0.35 | 0.29 | 0.24 | 0.21 |
| EPS Basic Continuous Ops | 0.42 | 0.35 | 0.30 | 0.12 | 0.42 |
| EPS Diluted Total Ops | 0.42 | 0.35 | 0.30 | 0.12 | 0.21 |
| EPS Diluted Continuous Ops | 0.42 | 0.35 | 0.30 | 0.12 | 0.21 |
| EBITDA(a) | $1,372,920 | $1,249,354 | $1,078,113 | $737,147 | $676,518 |